[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
September 24, 2014

Implementing Lung Cancer Screening Under Medicare: The Last Chance to Get It Right?

Author Affiliations
  • 1The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
  • 2Patient-Centered Outcomes Research Institute, Washington, DC
 

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2014;312(12):1206-1207. doi:10.1001/jama.2014.12921

In 2010, the investigators of the randomized National Lung Screening Trial (NLST) reported that annual screening with low-dose computed tomography (CT) reduced lung cancer mortality by 20% compared with screening with chest radiographs.1 Subsequently, several clinical practice guidelines recommended annual screening, and many insurers agreed to cover screening. Most recently, the US Preventive Services Task Force (USPSTF) recommended annual screening for 55- to 80-year-old individuals who had smoked at least 30 pack-years.2

×